Molekulargenetische Diagnostik
Praxis Dr. Mato Nagel

Wachstumshormon-Überempfindlichkeit

Die Überempfindlichkeit gegenüber Wachstumshormon außert sich in einem vermehrten Ansprechen des Wachstumshormon-Rezeptors gegenüber dem Hormon was damit zu einem verstärkten Wachstum führt. Bisher ist nur eine Variation, die Deletion bzw. Nicht-Transkription des Exon 3 führt als Ursache einer solchen Störung bekannt.

Gliederung

Störungen der Regulation des Wachstums
Kleinwuchs, SHOX-bedingt
Kombinierter Hypophysenhormon-Mangel
Syndromale Wachstumsstörung
Wachstumshormon-Mangel
Wachstumshormon-Unempfindlichkeit
Wachstumshormon-Überempfindlichkeit
GHR

Referenzen:

1.

Horan M et al. (2006) Genetic variation at the growth hormone (GH1) and growth hormone receptor (GHR) loci as a risk factor for hypertension and stroke.

[^]
2.

Goddard AD et al. (1995) Mutations of the growth hormone receptor in children with idiopathic short stature. The Growth Hormone Insensitivity Study Group.

[^]
3.

Iida K et al. (1999) Functional characterization of truncated growth hormone (GH) receptor-(1-277) causing partial GH insensitivity syndrome with high GH-binding protein.

[^]
4.

Shuto Y et al. (1999) Reduced growth hormone receptor messenger ribonucleic acid in an aged man with chronic malnutrition and growth hormone resistance.

[^]
5.

Amit T et al. (2000) Clinical review 112: Does serum growth hormone (GH) binding protein reflect human GH receptor function?

[^]
6.

Pantel J et al. (2000) Species-specific alternative splice mimicry at the growth hormone receptor locus revealed by the lineage of retroelements during primate evolution.

[^]
7.

Ballesteros M et al. (2000) Distribution and abundance of messenger ribonucleic acid for growth hormone receptor isoforms in human tissues.

[^]
8.

Stofega MR et al. (2000) Mutation of the SHP-2 binding site in growth hormone (GH) receptor prolongs GH-promoted tyrosyl phosphorylation of GH receptor, JAK2, and STAT5B.

[^]
9.

Gastier JM et al. (2000) Diverse deletions in the growth hormone receptor gene cause growth hormone insensitivity syndrome.

[^]
10.

Leung KC et al. (2000) Insulin regulation of human hepatic growth hormone receptors: divergent effects on biosynthesis and surface translocation.

[^]
11.

Fisker S et al. (2001) Gene expression of a truncated and the full-length growth hormone (GH) receptor in subcutaneous fat and skeletal muscle in GH-deficient adults: impact of GH treatment.

[^]
12.

Metherell LA et al. (2001) Pseudoexon activation as a novel mechanism for disease resulting in atypical growth-hormone insensitivity.

[^]
13.

Jorge AA et al. (2002) Poor reproducibility of IGF-I and IGF binding protein-3 generation test in children with short stature and normal coding region of the GH receptor gene.

[^]
14.

Marzullo P et al. (2002) Leptin concentrations in GH deficiency: the effect of GH insensitivity.

[^]
15.

Pantel J et al. (2003) Heterozygous nonsense mutation in exon 3 of the growth hormone receptor (GHR) in severe GH insensitivity (Laron syndrome) and the issue of the origin and function of the GHRd3 isoform.

[^]
16.

Berg MA et al. (1992) Mutation creating a new splice site in the growth hormone receptor genes of 37 Ecuadorean patients with Laron syndrome.

[^]
17.

Takada D et al. (2003) Growth hormone receptor variant (L526I) modifies plasma HDL cholesterol phenotype in familial hypercholesterolemia: intra-familial association study in an eight-generation hyperlipidemic kindred.

[^]
18.

Fielder PJ et al. (1992) Expression of serum insulin-like growth factors, insulin-like growth factor-binding proteins, and the growth hormone-binding protein in heterozygote relatives of Ecuadorian growth hormone receptor deficient patients.

[^]
19.

Milward A et al. (2004) Growth hormone (GH) insensitivity syndrome due to a GH receptor truncated after Box1, resulting in isolated failure of STAT 5 signal transduction.

[^]
20.

Dos Santos C et al. (2004) A common polymorphism of the growth hormone receptor is associated with increased responsiveness to growth hormone.

[^]
21.

Tiulpakov A et al. (2005) A novel C-terminal growth hormone receptor (GHR) mutation results in impaired GHR-STAT5 but normal STAT-3 signaling.

[^]
22.

Greenhalgh CJ et al. (2005) SOCS2 negatively regulates growth hormone action in vitro and in vivo.

[^]
23.

Jorge AA et al. (2006) Growth hormone (GH) pharmacogenetics: influence of GH receptor exon 3 retention or deletion on first-year growth response and final height in patients with severe GH deficiency.

[^]
24.

Binder G et al. (2006) The d3-growth hormone (GH) receptor polymorphism is associated with increased responsiveness to GH in Turner syndrome and short small-for-gestational-age children.

[^]
25.

Carrascosa A et al. (2006) The d3/fl-growth hormone (GH) receptor polymorphism does not influence the effect of GH treatment (66 microg/kg per day) or the spontaneous growth in short non-GH-deficient small-for-gestational-age children: results from a two-year controlled prospective study in 170 Spanish patients.

[^]
26.

Audí L et al. (2006) Exon 3-deleted/full-length growth hormone receptor polymorphism genotype frequencies in Spanish short small-for-gestational-age (SGA) children and adolescents (n = 247) and in an adult control population (n = 289) show increased fl/fl in short SGA.

[^]
27.

Kenth G et al. (2007) Relationship of the human growth hormone receptor exon 3 genotype with final adult height and bone mineral density.

[^]
28.

David A et al. (2007) An intronic growth hormone receptor mutation causing activation of a pseudoexon is associated with a broad spectrum of growth hormone insensitivity phenotypes.

[^]
29.

Duquesnoy P et al. (1991) Defective membrane expression of human growth hormone (GH) receptor causes Laron-type GH insensitivity syndrome.

[^]
30.

Fang P et al. (2007) Primary growth hormone (GH) insensitivity and insulin-like growth factor deficiency caused by novel compound heterozygous mutations of the GH receptor gene: genetic and functional studies of simple and compound heterozygous states.

[^]
31.

Jensen RB et al. (2007) The presence of the d3-growth hormone receptor polymorphism is negatively associated with fetal growth but positively associated with postnatal growth in healthy subjects.

[^]
32.

Asa SL et al. (2007) A growth hormone receptor mutation impairs growth hormone autofeedback signaling in pituitary tumors.

[^]
33.

Schreiner F et al. (2007) Association of the growth hormone receptor d3-variant and catch-up growth of preterm infants with birth weight of less than 1500 grams.

[^]
34.

Carrascosa A et al. (2008) Growth hormone (GH) dose, but not exon 3-deleted/full-length GH receptor polymorphism genotypes, influences growth response to two-year GH Therapy in Short Small-for-Gestational-Age Children.

[^]
35.

Räz B et al. (2008) Influence of growth hormone (GH) receptor deletion of exon 3 and full-length isoforms on GH response and final height in patients with severe GH deficiency.

[^]
36.

van der Klaauw AA et al. (2008) Influence of the d3-growth hormone (GH) receptor isoform on short-term and long-term treatment response to GH replacement in GH-deficient adults.

[^]
37.

Audí L et al. (2008) The exon 3-deleted/full-length growth hormone receptor polymorphism does not influence the effect of puberty or growth hormone therapy on glucose homeostasis in short non-growth hormone-deficient small-for-gestational-age children: results from a two-year controlled prospective study.

[^]
38.

Mercado M et al. (2008) Clinical and biochemical impact of the d3 growth hormone receptor genotype in acromegaly.

[^]
39.

Amselem S et al. (1991) Recurrent nonsense mutations in the growth hormone receptor from patients with Laron dwarfism.

[^]
40.

Rubin CJ et. al. (2010) Whole-genome resequencing reveals loci under selection during chicken domestication.

[^]
41.

Rosenbloom AL et al. (1990) The little women of Loja--growth hormone-receptor deficiency in an inbred population of southern Ecuador.

[^]
42.

Arden KC et al. (1990) The receptors for prolactin and growth hormone are localized in the same region of human chromosome 5.

[^]
43.

Barton DE et al. (1989) Chromosome mapping of the growth hormone receptor gene in man and mouse.

[^]
44.

Amselem S et al. (1989) Laron dwarfism and mutations of the growth hormone-receptor gene.

[^]
45.

Laron Z et al. (1989) Serum GH binding protein activities identifies the heterozygous carriers for Laron type dwarfism.

[^]
46.

Godowski PJ et al. (1989) Characterization of the human growth hormone receptor gene and demonstration of a partial gene deletion in two patients with Laron-type dwarfism.

[^]
47.

Leung DW et al. () Growth hormone receptor and serum binding protein: purification, cloning and expression.

[^]
48.

Spencer SA et al. (1988) Rabbit liver growth hormone receptor and serum binding protein. Purification, characterization, and sequence.

[^]
49.

Edery M et al. (1993) Lack of hormone binding in COS-7 cells expressing a mutated growth hormone receptor found in Laron dwarfism.

[^]
50.

Berg MA et al. (1993) Diverse growth hormone receptor gene mutations in Laron syndrome.

[^]
51.

Woods KA et al. (1996) A homozygous splice site mutation affecting the intracellular domain of the growth hormone (GH) receptor resulting in Laron syndrome with elevated GH-binding protein.

[^]
52.

Stallings-Mann ML et al. (1996) Alternative splicing of exon 3 of the human growth hormone receptor is the result of an unusual genetic polymorphism.

[^]
53.

Ayling RM et al. (1997) A dominant-negative mutation of the growth hormone receptor causes familial short stature.

[^]
54.

Menon RK et al. (1997) Identification and characterization of single strand DNA-binding protein that represses growth hormone receptor gene expression.

[^]
55.

Kaji H et al. (1997) Novel compound heterozygous mutations of growth hormone (GH) receptor gene in a patient with GH insensitivity syndrome.

[^]
56.

Amit T et al. (1997) A membrane-fixed, truncated isoform of the human growth hormone receptor.

[^]
57.

Iida K et al. (1998) Growth hormone (GH) insensitivity syndrome with high serum GH-binding protein levels caused by a heterozygous splice site mutation of the GH receptor gene producing a lack of intracellular domain.

[^]
58.

Kranzler JH et al. (1998) Normal intelligence with severe insulin-like growth factor I deficiency due to growth hormone receptor deficiency: a controlled study in a genetically homogeneous population.

[^]
59.

Rosenbloom AL et al. (1998) Stature in Ecuadorians heterozygous for growth hormone receptor gene E180 splice mutation does not differ from that of homozygous normal relatives.

[^]
60.

Shen XY et al. (1998) Cirrhotic liver expresses low levels of the full-length and truncated growth hormone receptors.

[^]
61.

Walker JL et al. (1998) A novel mutation affecting the interdomain link region of the growth hormone receptor in a Vietnamese girl, and response to long-term treatment with recombinant human insulin-like growth factor-I and luteinizing hormone-releasing hormone analogue.

[^]
62.

Sanchez JE et al. (1998) Growth hormone receptor mutations in children with idiopathic short stature.

[^]
63.

Wojcik J et al. (1998) Four contiguous amino acid substitutions, identified in patients with Laron syndrome, differently affect the binding affinity and intracellular trafficking of the growth hormone receptor.

[^]